Lung researchers at VUMC win prestigious fellowships
Two early-career faculty members in the Division of Allergy, Pulmonary and Critical Care Medicine, Scott McCall, MD, PhD, and Kevin Seitz, MD, MSc, have been awarded prestigious fellowships by the…
VUMC study takes closer look at how pulmonary fibrosis unfolds
The research study, co-authored by VUMC’s Jonathan Kropski, MD, could point to future therapeutic strategies that treat PF patients based on their individual stage of cellular and molecular…
Two VUMC physician-scientists named to medical honor society
Jonathan Kropski, MD, of the Pulmonary Fibrosis Research Group, has been elected to membership in the American Society for Clinical Investigation (ASCI), one of the nation’s oldest and most…
Study suggests a new way to treat incurable lung disease
IPF is one of the most common forms of pulmonary fibrosis, an interstitial lung disease characterized by the progressive accumulation of scar tissue (fibrosis) in the epithelial lining of the…
Studies to explore molecular drivers of pulmonary diseases
Three grants, totaling over $22 million, were awarded by the National Institutes of Health’s National Heart, Lung, and Blood Institute and will be led by a team of VUMC investigators.